New Paper Looks at Assessment of Risks and Benefits of Beta Cell Replacement Versus Automated Insulin Delivery Systems for Type 1 Diabetes
Posted date: September 08, 2020
A figure from the publication.
A paper from Diabetes Action Canada researchers Drs. Peter Senior, Bruce Perkins and Remi Rabasa-Lhoret, along with Patient Partner Kate Farnsworth, was recently released in the journal Springer Nature.